Phase II Study of Pegylated Liposomal Doxorubicin (Doxil) and Temsirolimus (Torisel) in Patients With Advanced Hepatocellular Cancer
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 03 Jul 2013
At a glance
- Drugs Doxorubicin liposomal (Primary) ; Temsirolimus (Primary)
- Indications Liver cancer
- Focus Pharmacogenomic; Therapeutic Use
- 31 Oct 2012 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 20 Jun 2011 Planned end date changed from Jul 2012 to May 2014 as reported by ClinicalTrials.gov.
- 20 Jun 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.